Expression-Dependent Tumor Pretargeting via Engineered Avidity

Keyphrases

• Amino Acids 100%
• Tumor 100%
• Bispecific 100%
• Tumor Cells 100%
• Tumor Targeting 100%
• Trivalent 100%
• Nanobody 100%
• Linker 100%
• Healthy Tissue 100%
• Retargeting 100%
• Folate Receptor 100%
• Affibody 100%
• Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 100%
• In Cancer 50%
• Cellular Biomarkers 50%
• Cancer Treatment 50%
• Design Principles 50%
• High Affinity 50%
• Expression Level 50%
• High Density 50%
• Advanced Technologies 50%
• Low Affinity 50%
• Radioligand Therapy 50%
• Binding Affinity 50%
• Therapeutic Modalities 50%
• Tumor Tissue 50%
• Mixed Culture 50%
• Selective Delivery 50%
• Tumor Selectivity 50%
• Linker Length 50%
• Specific Biomarkers 50%
• Therapeutic Window 50%
• Soluble Antigen 50%
• Affibody Molecule 50%
• Multivalent Antibody 50%
• Tumor Activity 50%
• α-peptide 50%
• Shed Antigen 50%
• Polypeptide Linker 50%

Biochemistry, Genetics and Molecular Biology

• Avidity 100%
• Amino Acids 66%
• Affibody 66%
• Cell Adhesion Proteins 66%
• Carcinoembryonic Antigen 66%
• Single-Domain Antibody 66%
• Folate Receptor 1 66%
• Radioligand 33%
• Binding Affinity 33%
• Mixed Cell Culture 33%
• Affibody Molecule 33%